Literature DB >> 12421220

Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration.

David F Stroncek1, Tobie Rainer, Victoria Sharon, Karen M Byrne, Constance T Noguchi, Harvey G Klein, Alan N Schechter, Susan F Leitman.   

Abstract

BACKGROUND: RBC components collected from donors with sickle cell trait frequently occlude WBC-reduction filters. In vitro, sickle trait RBCs have the potential for sickle Hb (Hb S) polymerization at low oxygen saturations and high Hb concentrations. STUDY DESIGN AND
METHOD: To determine if the low pH and high osmolarity of the CP2D used in the collection contributed to filter failures, the filterability of sickle trait donor RBCs collected in CP2D was compared with RBCs from the same donors collected in heparin.
RESULTS: Five of six sickle trait components collected in CP2D did not complete filtration, but all six RBC components collected in heparin filtered completely. RBC components collected in CP2D from four other sickle trait donors were divided in two, and one-half was treated with carbon monoxide to convert Hb S to its liganded form to prevent Hb S polymerization. All four carbon monoxide-treated components filtered within 9 minutes, but only one untreated component filtered completely. RBC components collected by apheresis contained less CP2D, and five of seven sickle trait apheresis components filtered completely; four of the five filtered rapidly (<15 min) and one filtered in 100 minutes. Hb oxygen saturation was greater in the four rapidly filtering apheresis RBC components (68 +/- 9%) than in the three that filtered slowly or incompletely (37 +/- 5%, p = 0.03).
CONCLUSIONS: Hb S polymerization appears responsible for RBC WBC-reduction filter failures. Citrate anticoagulant and low oxygen saturation are responsible in part for Hb S polymerization in this setting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421220     DOI: 10.1046/j.1537-2995.2002.00206.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications.

Authors:  Jonathan C Goldsmith; Vence L Bonham; Clinton H Joiner; Gregory J Kato; Allan S Noonan; Martin H Steinberg
Journal:  Am J Hematol       Date:  2012-02-03       Impact factor: 10.047

Review 2.  An outcome-based review of an accredited Specialist in Blood Banking (SBB) program: 25 years and counting.

Authors:  Karen M Byrne; Traci D Paige; Willy A Flegel
Journal:  Immunohematology       Date:  2020-01

3.  Assessment of leucoreduction of sickle cell trait blood: quality of the filtered product.

Authors:  Karim Ould Amar; Olivier Bourdonné; Sylvie Bruneau; Fatiha Sellami; Pascale Richard
Journal:  Blood Transfus       Date:  2012-10-30       Impact factor: 3.443

4.  Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes.

Authors:  Tennille D Presley; Andreas S Perlegas; Lauren E Bain; Samir K Ballas; James S Nichols; Hernan Sabio; Mark T Gladwin; Gregory J Kato; Daniel B Kim-Shapiro
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

5.  Prevalence of glucose-6-phosphate dehydrogenase deficiency and sickle cell trait among blood donors in Riyadh.

Authors:  Mohammed K Alabdulaali; Khaled M Alayed; Abdulaziz F Alshaikh; Shihab A Almashhadani
Journal:  Asian J Transfus Sci       Date:  2010-01

6.  Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice.

Authors:  David O Osei-Hwedieh; Tamir Kanias; Claudette St Croix; Morgan Jessup; Zeyu Xiong; Derek Sinchar; Jonathan Franks; Qinzi Xu; Enrico M Novelli; Jonas T Sertorio; Karin Potoka; Robert J Binder; Swati Basu; Andrea M Belanger; Daniel B Kim-Shapiro; Darrell Triulzi; Janet S Lee; Mark T Gladwin
Journal:  EBioMedicine       Date:  2016-08-04       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.